{"id":"https://openalex.org/W2139183362","doi":"https://doi.org/10.1021/jm9905561","title":"Further SAR Studies of Piperidine-Based Analogues of Cocaine. 2. Potent Dopamine and Serotonin Reuptake Inhibitors","display_name":"Further SAR Studies of Piperidine-Based Analogues of Cocaine. 2. Potent Dopamine and Serotonin Reuptake Inhibitors","publication_year":2000,"publication_date":"2000-02-25","ids":{"openalex":"https://openalex.org/W2139183362","doi":"https://doi.org/10.1021/jm9905561","mag":"2139183362","pmid":"https://pubmed.ncbi.nlm.nih.gov/10737754"},"language":"en","primary_location":{"id":"doi:10.1021/jm9905561","doi":"https://doi.org/10.1021/jm9905561","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm9905561","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020276346","display_name":"Amir P. Tamiz","orcid":"https://orcid.org/0000-0002-5345-970X","observed_orcids":["https://orcid.org/0000-0002-5345-970X"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amir P. Tamiz","raw_affiliation_strings":["Drug Discovery Program, Institute of Cognitive and Computational Science, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007-2197, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555-1031, and Laboratory for the Structure of Matter, Code 6030, Naval Research Laboratory, 4555 Overlook, SW, Washington, DC 20275-5000","GEORGETOWN UNIVERSITY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Program, Institute of Cognitive and Computational Science, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007-2197, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555-1031, and Laboratory for the Structure of Matter, Code 6030, Naval Research Laboratory, 4555 Overlook, SW, Washington, DC 20275-5000","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I55302922"]},{"raw_affiliation_string":"GEORGETOWN UNIVERSITY","institution_ids":["https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080902928","display_name":"Jianrong Zhang","orcid":"https://orcid.org/0000-0003-4688-5222","observed_orcids":["https://orcid.org/0000-0003-4688-5222","https://orcid.org/0009-0008-5855-5398"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jianrong Zhang","raw_affiliation_strings":["Drug Discovery Program, Institute of Cognitive and Computational Science, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007-2197, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555-1031, and Laboratory for the Structure of Matter, Code 6030, Naval Research Laboratory, 4555 Overlook, SW, Washington, DC 20275-5000","GEORGETOWN UNIVERSITY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Program, Institute of Cognitive and Computational Science, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007-2197, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555-1031, and Laboratory for the Structure of Matter, Code 6030, Naval Research Laboratory, 4555 Overlook, SW, Washington, DC 20275-5000","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I55302922"]},{"raw_affiliation_string":"GEORGETOWN UNIVERSITY","institution_ids":["https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103553547","display_name":"J.L. Flippen-Anderson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Judith L. Flippen-Anderson","raw_affiliation_strings":["Drug Discovery Program, Institute of Cognitive and Computational Science, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007-2197, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555-1031, and Laboratory for the Structure of Matter, Code 6030, Naval Research Laboratory, 4555 Overlook, SW, Washington, DC 20275-5000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Program, Institute of Cognitive and Computational Science, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007-2197, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555-1031, and Laboratory for the Structure of Matter, Code 6030, Naval Research Laboratory, 4555 Overlook, SW, Washington, DC 20275-5000","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I55302922"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mei Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mei Zhang","raw_affiliation_strings":["Drug Discovery Program, Institute of Cognitive and Computational Science, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007-2197, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555-1031, and Laboratory for the Structure of Matter, Code 6030, Naval Research Laboratory, 4555 Overlook, SW, Washington, DC 20275-5000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Program, Institute of Cognitive and Computational Science, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007-2197, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555-1031, and Laboratory for the Structure of Matter, Code 6030, Naval Research Laboratory, 4555 Overlook, SW, Washington, DC 20275-5000","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I55302922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090421340","display_name":"Kenneth M. Johnson","orcid":"https://orcid.org/0000-0001-5621-0312","observed_orcids":["https://orcid.org/0000-0001-5621-0312"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth M. Johnson","raw_affiliation_strings":["Drug Discovery Program, Institute of Cognitive and Computational Science, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007-2197, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555-1031, and Laboratory for the Structure of Matter, Code 6030, Naval Research Laboratory, 4555 Overlook, SW, Washington, DC 20275-5000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Program, Institute of Cognitive and Computational Science, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007-2197, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555-1031, and Laboratory for the Structure of Matter, Code 6030, Naval Research Laboratory, 4555 Overlook, SW, Washington, DC 20275-5000","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I55302922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074101024","display_name":"Olivier Deschaux","orcid":"https://orcid.org/0000-0002-6762-2264","observed_orcids":["https://orcid.org/0000-0002-6762-2264"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olivier Deschaux","raw_affiliation_strings":["Drug Discovery Program, Institute of Cognitive and Computational Science, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007-2197, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555-1031, and Laboratory for the Structure of Matter, Code 6030, Naval Research Laboratory, 4555 Overlook, SW, Washington, DC 20275-5000","GEORGETOWN UNIVERSITY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Program, Institute of Cognitive and Computational Science, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007-2197, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555-1031, and Laboratory for the Structure of Matter, Code 6030, Naval Research Laboratory, 4555 Overlook, SW, Washington, DC 20275-5000","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I55302922"]},{"raw_affiliation_string":"GEORGETOWN UNIVERSITY","institution_ids":["https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054655637","display_name":"Srihari R. Tella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srihari Tella","raw_affiliation_strings":["Drug Discovery Program, Institute of Cognitive and Computational Science, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007-2197, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555-1031, and Laboratory for the Structure of Matter, Code 6030, Naval Research Laboratory, 4555 Overlook, SW, Washington, DC 20275-5000","GEORGETOWN UNIVERSITY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Program, Institute of Cognitive and Computational Science, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007-2197, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555-1031, and Laboratory for the Structure of Matter, Code 6030, Naval Research Laboratory, 4555 Overlook, SW, Washington, DC 20275-5000","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I55302922"]},{"raw_affiliation_string":"GEORGETOWN UNIVERSITY","institution_ids":["https://openalex.org/I184565670"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026395120","display_name":"Alan P. Kozikowski","orcid":"https://orcid.org/0000-0003-4795-5368","observed_orcids":["https://orcid.org/0000-0003-4795-5368","https://orcid.org/0009-0004-2541-2826"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan P. Kozikowski","raw_affiliation_strings":["Drug Discovery Program, Institute of Cognitive and Computational Science, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007-2197, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555-1031, and Laboratory for the Structure of Matter, Code 6030, Naval Research Laboratory, 4555 Overlook, SW, Washington, DC 20275-5000","GEORGETOWN UNIVERSITY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Program, Institute of Cognitive and Computational Science, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007-2197, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555-1031, and Laboratory for the Structure of Matter, Code 6030, Naval Research Laboratory, 4555 Overlook, SW, Washington, DC 20275-5000","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I55302922"]},{"raw_affiliation_string":"GEORGETOWN UNIVERSITY","institution_ids":["https://openalex.org/I184565670"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":2.7082,"has_fulltext":false,"cited_by_count":44,"citation_normalized_percentile":{"value":0.90752688,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"43","issue":"6","first_page":"1215","last_page":"1222"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.5508000254631042,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.5508000254631042,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","score":0.21369999647140503,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12649","display_name":"Alkaloids: synthesis and pharmacology","score":0.060499999672174454,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cocaine-analogs","display_name":"cocaine analogues","score":0.8190000057220459},{"id":"https://openalex.org/keywords/piperidine-derivatives","display_name":"piperidine derivatives","score":0.7580000162124634},{"id":"https://openalex.org/keywords/dopamine-transporter-inhibitors","display_name":"dopamine transporter inhibitors","score":0.7649999856948853},{"id":"https://openalex.org/keywords/serotonin-transporter-inhibitors","display_name":"serotonin transporter inhibitors","score":0.9240000247955322},{"id":"https://openalex.org/keywords/norepinephrine-transporter","display_name":"norepinephrine transporter","score":0.9070000052452087},{"id":"https://openalex.org/keywords/monoamine-transporters","display_name":"monoamine transporters","score":0.9200000166893005},{"id":"https://openalex.org/keywords/arecoline","display_name":"arecoline","score":0.6349999904632568},{"id":"https://openalex.org/keywords/stereoselectivity","display_name":"stereoselectivity","score":0.7260000109672546},{"id":"https://openalex.org/keywords/synaptosomes","display_name":"synaptosomes","score":0.6610000133514404},{"id":"https://openalex.org/keywords/stereotyped-behavior","display_name":"stereotypy","score":0.6919999718666077},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.36500000953674316}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9006974697113037},{"id":"https://openalex.org/C2781462491","wikidata":"https://www.wikidata.org/wiki/Q410234","display_name":"Piperidine","level":2,"score":0.7636598944664001},{"id":"https://openalex.org/C99631742","wikidata":"https://www.wikidata.org/wiki/Q22290476","display_name":"Reuptake","level":4,"score":0.6988013982772827},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.6842349767684937},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.6181237697601318},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.6147425770759583},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5388201475143433},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.2698386609554291},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1946362853050232},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15552324056625366},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.05984538793563843},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.047752052545547485}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008562","descriptor_name":"Membrane Glycoproteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009411","descriptor_name":"Nerve Endings","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009419","descriptor_name":"Nerve Tissue Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013239","descriptor_name":"Stereotyped Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D018765","descriptor_name":"Dopamine Uptake Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D018765","descriptor_name":"Dopamine Uptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018765","descriptor_name":"Dopamine Uptake Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D026901","descriptor_name":"Membrane Transport Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D050483","descriptor_name":"Dopamine Plasma Membrane Transport Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050486","descriptor_name":"Serotonin Plasma Membrane Transport Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm9905561","doi":"https://doi.org/10.1021/jm9905561","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm9905561","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:10737754","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10737754","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.7400000095367432,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1940562023","display_name":null,"funder_award_id":"DA-10458","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G6279525620","display_name":"CHEMICAL AND PHARMACOLOGICAL STUDIES OF COCAINE ANALOGS","funder_award_id":"R01DA010458","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W199743888","https://openalex.org/W1576239416","https://openalex.org/W1680855902","https://openalex.org/W1838134399","https://openalex.org/W1982954842","https://openalex.org/W1983375354","https://openalex.org/W1988237294","https://openalex.org/W1989449416","https://openalex.org/W1995336461","https://openalex.org/W1999331154","https://openalex.org/W2008344720","https://openalex.org/W2015745154","https://openalex.org/W2037911192","https://openalex.org/W2038924612","https://openalex.org/W2059671064","https://openalex.org/W2077615226","https://openalex.org/W2080402976","https://openalex.org/W2081890219","https://openalex.org/W2084259941","https://openalex.org/W2088678881","https://openalex.org/W2093708977","https://openalex.org/W2108750731","https://openalex.org/W2124755695","https://openalex.org/W2130068738","https://openalex.org/W2171847439","https://openalex.org/W2415670961","https://openalex.org/W2951832656","https://openalex.org/W2952698597"],"related_works":["https://openalex.org/W2108750731","https://openalex.org/W2143092648","https://openalex.org/W2028770152","https://openalex.org/W2012785054","https://openalex.org/W2070147672","https://openalex.org/W1984623446","https://openalex.org/W2072689887","https://openalex.org/W2063613276","https://openalex.org/W1991182193","https://openalex.org/W2085316187"],"abstract_inverted_index":{"The":[0,296],"synthesis":[1],"and":[2,37,53,80,94,122,128,317],"monoamine":[3,320],"transporter":[4,86,92],"activity":[5,134,230],"of":[6,9,12,17,25,48,63,77,119,135,142,171,189,197,213,275,312],"additional":[7],"members":[8,24],"a":[10,201],"series":[11,27,69],"3,4-disubstituted":[13],"piperidines":[14,161],"(truncated":[15],"analogues":[16],"the":[18,64,84,90,96,102,112,126,132,143,155,158,174,182,185,190,194,209,284,288,305,310],"WIN":[19],"series)":[20],"are":[21,70],"described.":[22],"All":[23],"this":[26,68],"were":[28,38],"prepared":[29,66],"from":[30,154,193],"arecoline":[31],"hydrobromide":[32],"in":[33,67,165,181,204,210,245,249,269,290,309],"optically":[34],"pure":[35],"form":[36],"evaluated":[39],"for":[40,83,173,184,302],"their":[41,166],"ability":[42],"to":[43,88,95,110,140,200,232,238,261],"inhibit":[44],"high":[45],"affinity":[46],"uptake":[47],"dopamine":[49],"(DA),":[50],"serotonin":[51],"(5-HT)":[52],"norepinephrine":[54],"(NE)":[55],"into":[56,283],"rat":[57],"brain":[58],"nerve":[59],"endings":[60],"(synaptosomes).":[61],"Most":[62],"compounds":[65],"reasonably":[71],"potent":[72,114,244,266],"DAT":[73,97,127,229,255],"inhibitors":[74],"(K(i)":[75],"values":[76],"4-400":[78],"nM)":[79],"have":[81,299],"selectivity":[82,172,318],"5-HT":[85],"relative":[87],"both":[89],"NE":[91],"(3-9-fold)":[93],"(":[98],"approximately":[99],"25-fold).":[100],"In":[101],"present":[103,297],"series,":[104],"(-)-methyl":[105],"1-methyl-4beta-(2-naphthyl)piperidine-3beta-carboxylate":[106],"(6)":[107],"was":[108,219,236,259],"found":[109,237,260],"be":[111,239,262],"most":[113],"piperidine-based":[115,277],"ligand,":[116],"exhibiting":[117],"K(i)'s":[118],"21":[120],"nM":[121,124],"7.6":[123],"at":[125,319],"5-HTT,":[129],"respectively.":[130],"While":[131],"5-HTT":[133,205],"compound":[136],"6":[137],"is":[138,148,152],"comparable":[139],"that":[141],"antidepressant":[144],"medication":[145],"fluoxetine,":[146],"it":[147],"less":[149,243],"selective.":[150],"As":[151],"apparent":[153],"data":[156],"presented,":[157],"naphthyl":[159],"substituted":[160],"6-9,":[162],"which":[163],"differ":[164],"stereochemistry,":[167],"show":[168],"different":[169],"degrees":[170],"three":[175],"transporters.":[176,321],"Consistent":[177],"with":[178,253,314],"results":[179,298],"reported":[180],"literature":[183],"tropane":[186],"analogues,":[187],"removal":[188],"methyl":[191],"group":[192],"nitrogen":[195],"atom":[196],"9":[198],"leads":[199],"further":[202],"enhancement":[203,289],"activity.":[206],"To":[207],"examine":[208],"vivo":[211],"effects":[212],"these":[214,276],"piperidines,":[215],"preliminary":[216],"behavioral":[217],"screening":[218],"carried":[220],"out":[221],"on":[222],"piperidine":[223,234,257],"14.":[224],"Despite":[225],"its":[226,254],"2.5-fold":[227,264],"greater":[228],"compared":[231],"cocaine,":[233],"14":[235,258],"about":[240,263],"2.":[241],"5-fold":[242],"increasing":[246],"distance":[247,291],"traveled":[248,292],"mice.":[250],"However,":[251],"consistent":[252],"activity,":[256],"more":[265],"than":[267],"cocaine":[268],"enhancing":[270],"stereotypic":[271,294],"movements.":[272,295],"Further":[273],"studies":[274],"ligands":[278],"may":[279],"provide":[280],"valuable":[281],"insights":[282],"pharmacological":[285],"mechanisms":[286],"underlying":[287],"versus":[293],"important":[300],"implications":[301],"better":[303],"understanding":[304],"structural":[306],"motifs":[307],"required":[308],"design":[311],"agents":[313],"specific":[315],"potency":[316]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}